NCT02701699View on ClinicalTrials.gov

18F-Fluoroazomycin Arabinoside (18F-FAZA) in Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Lung Cancer
Interventions
BIOLOGICAL

18-F-FAZA

All patients enrolled in this study will receive a FAZA PET Scan prior to their first radiation therapy fraction

Trial Locations (1)

M5G 2M9

RECRUITING

University Health Network, Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER